The product can not be sold in a country where it is illegal.
Buy MMB-Chminaca for sale online from USA vendor
Specification
Product Name:
MMB-CHMINACA
IUPAC Name:
methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate
Other Names:
MDMB-CHMICA,MMBC
Cas Number:
1715016-78-6
Molecular Formula:
C23H32N2O3
Molar Mass:
384.51 g/mol
Effect:
stimulant, psychedelic, cannabinoid
Purity of the substance:
≥99.3%
Physical properties:
Crystals, powder
In Stock
Shipping:
- FREE 7 days from China
- INSURANCE option is local shipping from distributor in your country.
FREE & 3 Day Shipping
Payments: WU, MG, Bank Transfer , Pay with Bitcoin - get
10% OFF
Get FREE five samples 2 grams each for the main order.
What is MMB-Chminaca?
MMB-Chminaca is a synthetic cannabinoid often used as a research chemical. It is a part of a group of substances known as "designer drugs" that are chemically similar to THC, the active ingredient in cannabis. MMB-Chminaca is not approved for human consumption and is typically used for scientific studies.
What are the effects of MMB-Chminaca?
The effects of MMB-Chminaca include psychoactive and cannabinoid-like effects. Users may experience relaxation, euphoria, altered perceptions, and sometimes intense sedation. However, the effects vary significantly between individuals and may cause unpredictable reactions, including anxiety, paranoia, and hallucinations.
Is MMB-Chminaca legal?
The legality of MMB-Chminaca depends on the country or region. In many places, it is considered a controlled substance due to its similarity to other synthetic cannabinoids, which are often banned. However, some countries or regions may not have specific legislation against it, making it legally ambiguous.
Can MMB-Chminaca be used for medical purposes?
MMB-Chminaca is not approved for medical use and has no recognized therapeutic benefits. It is classified as a research chemical, meaning it should only be used in controlled, scientific environments. Its safety profile is not well understood, and it can pose significant health risks.
What are the risks of using MMB-Chminaca?
Using MMB-Chminaca carries significant risks, including severe health complications such as increased heart rate, anxiety, agitation, nausea, and in extreme cases, seizures, and organ damage. As with other synthetic cannabinoids, there is also the risk of overdose, which can be life-threatening.
Is MMB-Chminaca addictive?
There is limited information on the addictive potential of MMB-Chminaca. However, synthetic cannabinoids, in general, can lead to psychological dependence due to their euphoric effects. Regular use may result in tolerance, prompting users to consume higher doses, increasing the risk of adverse effects and addiction.
How is MMB-Chminaca consumed?
MMB-Chminaca is usually smoked, often mixed with plant material or inhaled via vaporization. In some cases, it may also be ingested or applied in liquid form. The method of consumption can significantly influence the onset and intensity of effects, and inhalation poses significant respiratory risks.
What are the symptoms of an overdose of MMB-Chminaca?
Symptoms of an overdose from MMB-Chminaca may include extreme agitation, confusion, seizures, rapid heart rate, vomiting, and unconsciousness. If an overdose is suspected, immediate medical attention is critical. In severe cases, overdose can lead to coma or death.
What should I do if I or someone I know is affected by MMB-Chminaca?
If you suspect someone has been affected by MMB-Chminaca, it is crucial to seek medical help immediately. Call emergency services or poison control. Do not attempt to treat the overdose without professional assistance, as complications can worsen without proper medical intervention.
Can MMB-Chminaca be detected in drug tests?
MMB-Chminaca may not be specifically tested for in standard drug screenings, but it could potentially show up in specialized tests for synthetic cannabinoids. Detection largely depends on the sensitivity of the test and the timing of the use.
Are there any long-term effects of using MMB-Chminaca?
The long-term effects of MMB-Chminaca are not well-documented, but synthetic cannabinoids, in general, may lead to lasting psychological and physical health problems. Chronic use can result in mental health issues like anxiety, depression, and cognitive impairment, as well as potential damage to the cardiovascular and respiratory systems.
Is MMB-Chminaca banned in all countries?
No, MMB-Chminaca is not banned in all countries. Its legal status varies depending on local regulations. In many regions, it is controlled or banned due to its harmful effects and potential for abuse, but there are areas where its status is unclear or not specifically regulated.
How can I avoid exposure to MMB-Chminaca?
The best way to avoid exposure to MMB-Chminaca is by avoiding substances that are labeled as synthetic cannabinoids or research chemicals. Be cautious when purchasing drugs online or from unregulated sources. If you are uncertain about the safety of a substance, it is important to seek advice from a healthcare professional.
What should I do if I have a question about MMB-Chminaca?
If you have concerns or questions regarding MMB-Chminaca, it is best to consult a healthcare provider, a toxicologist, or a local poison control center. Avoid using the drug and seek professional advice before making any decisions regarding synthetic cannabinoids or similar substances.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
Other Products:
1kg $1590
1kg $1590
1kg $1590
500g $1080
100mg $840
1kg $2100
1kg $1590
1kg $1590
1kg $1690
out of stock
500g $1199

